Attached files
| file | filename |
|---|---|
| EX-32.2 - Yubo International Biotech Ltd | e619787_ex32-2.htm |
| EX-31.2 - Yubo International Biotech Ltd | e619787_ex31-2.htm |
| EX-31.1 - Yubo International Biotech Ltd | e619787_ex31-1.htm |
| 10-Q - Yubo International Biotech Ltd | e619787_10q-magna.htm |
EXHIBIT 32.1: CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
In connection with the accompanying Quarterly report on Form 10-Q of Magna-Lab, Inc. for the quarter ended May 31, 2020, the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
| (1) | such Quarterly report on Form 10-Q for the quarter ended May 31, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in such Quarterly report on Form 10-Q for the quarter ended May 31, 2020 fairly presents, in all material respects, the financial condition and results of operations of Magna-Lab, Inc. |
| July 20, 2020 | /s/ David Lazar | |||
Name: David Lazar Title: CEO |